成纤维网状细胞来源外泌体治疗脓毒症急性肾损伤
该研究在盲肠结扎穿孔诱导的脓毒症小鼠模型中证实,成纤维网状细胞来源外泌体(FRC-Exos)可归巢至损伤肾脏并改善肾功能。机制上,FRC-Exos通过CD5L促进PINK1/Parkin依赖的线粒体自噬、抑制NLRP3炎症小体活化,经LTH肽修饰后靶向肾小管细胞,提高脓毒症生存率。
要点
- FRC-Exos可归巢至脓毒症损伤肾脏并改善肾功能
- CD5L是FRC-Exos中较巨噬细胞外泌体上调最显著的蛋白
- LTH肽修饰的CD5L富集FRC-Exos靶向肾小管细胞增强疗效
核心结论
- FRC-Exos可改善盲肠结扎穿孔诱导的脓毒症小鼠肾功能并提高生存率。
- 修饰FRC-Exos是开发肾脏损伤治疗新策略的潜在方向。
研究设计与样本
- 研究采用C57BL/6小鼠盲肠结扎穿孔诱导脓毒症模型。
- 体外使用LPS刺激的原代肾小管细胞(PKTCs)进行机制研究。
- 通过RNA-Seq、质谱、活体成像及CD5L慢病毒修饰和LTH肽修饰等方法开展实验。
主要发现
- 活体成像证实FRC-Exos归巢至损伤肾脏。
- FRC-Exos促进LPS刺激PKTCs中PINK1依赖的线粒体自噬并抑制NLRP3炎症小体活化。
- 质谱显示CD5L在FRC-Exos中较巨噬细胞来源外泌体上调最显著。
- 重组CD5L体外减轻LPS刺激后肾细胞肿胀和表面泡形成。
- LTH肽修饰的CD5L富集FRC-Exos选择性结合PKTCs,促进Parkin介导的线粒体自噬、抑制焦亡并改善肾功能和生存率。
临床怎么用
- FRC-Exos经CD5L和LTH肽修饰后可能作为靶向肾小管细胞的脓毒症急性肾损伤治疗候选。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sepsis-induced acute kidney injury (S-AKI) is highly lethal, and effective drugs for treatment are scarce. Previously, we reported the robust therapeutic efficacy of fibroblastic reticular cells (FRCs) in sepsis. Here, we demonstrate the ability of FRC-derived exosomes (FRC-Exos) to improve C57BL/6 mouse kidney function following cecal ligation and puncture-induced sepsis. In vivo imaging confirmed that FRC-Exos homed to injured kidneys. RNA-Seq analysis of FRC-Exo-treated primary kidney tubular cells (PKTCs) revealed that FRC-Exos influenced PKTC fate in the presence of lipopolysaccharide (LPS). FRC-Exos promoted kinase PINK1-dependent mitophagy and inhibited NLRP3 inflammasome activation in LPS-stimulated PKTCs. To dissect the mechanism underlying the protective role of Exos in S-AKI, we examined the proteins within Exos by mass spectrometry and found that CD5L was the most upregulated protein in FRC-Exos compared to macrophage-derived Exos. Recombinant CD5L treatment in vitro attenuated kidney cell swelling and surface bubble formation after LPS stimulation. FRCs were infected with a CD5L lentivirus to increase CD5L levels in FRC-Exos, which were then modified in vitro with the kidney tubular cell targeting peptide LTH, a peptide that binds to the biomarker protein kidney injury molecule-1 expressed on injured tubule cells, to enhance binding specificity. Compared with an equivalent dose of recombinant CD5L, the modified CD5L-enriched FRC-Exos selectively bound PKTCs, promoted kinase PINK-ubiquitin ligase Parkin-mediated mitophagy, inhibiting pyroptosis and improved kidney function by hindering NLRP3 inflammasome activation, thereby improving the sepsis survival rate. Thus, strategies to modify FRC-Exos could be a new avenue in developing therapeutics against kidney injury.
引用
- Li Y, Hu C, Zhai P, et al. Fibroblastic reticular cell-derived exosomes are a promising therapeutic approach for septic acute kidney injury. Kidney Int. 2023. PMID: 38163633. doi:10.1016/j.kint.2023.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。